Treatment Trends In Management Of Intracranial Stenosis In The Pre- And Post-Sammpris Era (I8-1.008)

DISCUSSION: SAMMPRIS had a major impact on treatment trends of physicians managing patients with intracranial stenosis. In the Post-SAMMPRIS survey, 91% of respondents participating in SAMMPRIS and 82% of overall respondents indicated that the SAMMPRIS results changed the way they managed patients with ICAS.As aggressive medical management coupled with optimal risk factor reduction shows promise in reducing rates of recurrent stroke, a novel endovascular therapy will have to seek newer heights of increasing RRR to gain acceptance by practitioners.Disclosure: Dr. Pawar has nothing to disclose. Dr. Turan has received personal compensation for activities with Gore Laboratories Inc., and Boehringer Ingelheim Pharmaceuticals Inc. Dr. Turan has received research support from Stryker Co., the National Institutes of Health, and AstraZeneca. Dr. Cotsonis has nothing to disclose. Dr. Lynn has nothing to disclose. Dr. Wooley has nothing to disclose. Dr. Stern has received personal compensation for activities with Lippincott Williams & Wilkins. Dr. Stern has received personal compensation in an editorial capacity for The Neurologist. Dr. Derdeyn has received personal compensation for activities with W.L. Gore and Associates, Boston Scientific Corporation, and Target Therapeutics. Dr. Fiorella has received personal compensation for activities with Covidien/ev3, Codman/Micrus/JNJ, NFocus, Vascular Simulations, CSVL, Microvention/Terumo, and Siemens Medical Imaging. Dr. FIorella has rec...
Source: Neurology - Category: Neurology Authors: Tags: Clinical Decision Making After the Dust Settles on Clinical Trials Poster Presentations Source Type: research